Implantica's offering was substantially oversubscribed – trading of the Swedish Depository Receipts on Nasdaq First North Premier Growth Market in Stockholm commences today, 21 September 2020
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. PLEASE READ "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.Implantica AG[1] (“Implantica” or the “Company”), a medtech group with operations within the implantable medical device and eHealth markets, announces today the outcome of the offering in connection